<DOC>
	<DOCNO>NCT02453893</DOCNO>
	<brief_summary>This research Randomized , double-blind , risperidone-controlled , multicenter clinical study . Chinese subject Ischemic Schizophrenia .</brief_summary>
	<brief_title>Risperidone-controlled , Multicentre Clinical Trial Iloperidone Patients With Schizophrenia</brief_title>
	<detailed_description>Subjects randomly enter one two group , period treatment 8 week .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>men woman age 18 65 year schizophrenia ; PANSS total score least 70 screening baseline ; least 2 4 point 7 PANSSP ; inform consent . allergy iloperidone risperidone ; psychotic symptom fail improve sufficient exposure 2 antipsychotic treatment ; primary Axis 1 psychiatric diagnosis ; history alcohol drug dependence recent 1 year ; imminent risk harm self others ; systolic blood pressure≤90mmHg。</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Iloperidone</keyword>
	<keyword>Risperidone</keyword>
	<keyword>PANSS</keyword>
</DOC>